It will be interesting to see how things develop from here. The...

It will be interesting to see how things develop from here. The timelines in latest update were certainly a lot longer that I ever expected. I guess nothing happens fast. On the plus side the burns trial has clearly started now which I would assume at least one patient is currently being dosed and the proposed dosing schedule was 14 days I believe. So one would assume data may possibly be available very shortly if not already. I guess it just depends what they chose to share. The longer they stay quiet the more holders may become nervous I suppose, myself included unfortunately.

For me it feels like I would just like some further confirmation this compound is safe in humans. To date we have the doctors self dose and sinusitis patient, which are both a great start.

If we could get good data on one or two initial burns patients that would make the wait for final data a lot less stressful.
on the plus side great financial position and it looks like a lot of ongoing costs are being listed as research and development which attract the generous rebates from government and possibly overseas sources for any research conducted off shore.